Latest stories on FHTX
Foghorn Therapeutics drops 44% after scrapping FHD-909 program
The Fly34 · bearishgeneral
Why is Foghorn Therapeutics stock plummeting today?
Investing.com Markets34 · bearishgeneral
Foghorn plunges as Lilly exits collaboration
Seeking Alpha28 · bearishgeneral
Foghorn to Slash 40% of Jobs as Lilly Cancer Partnership Falls Apart
Barron's28 · bearishgeneral
Foghorn, Lilly to not advance FHD-909 program, Foghorn to reduce workforce
The Fly28 · bearishgeneral
Foghorn Therapeutics Inc. (FHTX) files 8-K
SEC 8-K50 · neutralgeneral
Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities
Business Insider34 · bearishproduct/pr
Citizens reiterates Foghorn Therapeutics stock rating on trial data
Investing.com Analyst Ratings56 · neutralanalyst
Stifel reiterates Buy rating on Foghorn Therapeutics stock at $12
Investing.com Analyst Ratings61 · neutralanalyst
Foghorn Therapeutics GAAP EPS of -$0.10 beats by $0.14, revenue of $16.1M beats by $8.17M
Seeking Alpha63 · neutralearnings
Foghorn Therapeutics Inc. (FHTX) files 8-K
SEC 8-K50 · neutralgeneral
Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update
Business Insider55 · neutralgeneral
Foghorn Therapeutics Inc. (FHTX) files 8-K
SEC 8-K50 · neutralgeneral
Foghorn Therapeutics Inc. (FHTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral